Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Iversen

Showing results (71-80 of 156) with videos related to

Pageof 16
Sort By:
Journal of Surgical Oncology|March 11, 2014
Active surveillance for clinically localized prostate cancer--a systematic reviewFrederik B Thomsen, Klaus Brasso, Laurence H Klotz, et al.
EJNMMI Research|June 25, 2020
Extravasation of [<sup>177</sup>Lu]Lu-DOTATOC: case report and discussionAnne Kirstine Arveschoug, Anne Charlotte Bekker, Peter Iversen, et al.
BMJ Open|December 29, 2020
What is the risk of prostate cancer mortality following negative systematic TRUS-guided biopsies? A systematic reviewSandra Miriam Kawa, Signe Benzon Larsen, John Thomas Helgstrand, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 22, 2006
Peripheral benzodiazepine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathyPeter Iversen, Dorthe Aagaard Hansen, Dirk Bender, et al.
BJU International|June 15, 2006
Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castrationChris J Tyrrell, Peter Iversen, Teuvo Tammela, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 28, 2024
Whole-body parametric mapping of tumour perfusion in metastatic prostate cancer using long axial field-of-view [<sup>15</sup>O]H<sub>2</sub>O PETMads Ryø Jochumsen, Nana L Christensen, Peter Iversen, et al.
Scandinavian Journal of Urology|August 2, 2017
The risk of biochemical recurrence for intermediate-risk prostate cancer after radical prostatectomySorel Kurbegovic, Kasper Drimer Berg, Frederik Birkebæk Thomsen, et al.
The Lancet. Oncology|January 18, 2017
Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based studyNina Klemann, M Andreas Røder, J Thomas Helgstrand, et al.
Scandinavian Journal of Urology|March 9, 2018
The use of transrectal ultrasound-guided biopsy following the introduction of prostate-specific antigen testing in Denmark: a population-based analysisNina Klemann, Martin Andreas Røder, John Thomas Helgstrand, et al.
The Prostate|December 24, 2005
Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinomaKlaus Brasso, Ib Jarle Christensen, Julia S Johansen, et al.
Pageof 16

Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
Journal of Surgical Oncology|March 11, 2014
Active surveillance for clinically localized prostate cancer--a systematic reviewFrederik B Thomsen, Klaus Brasso, Laurence H Klotz, et al.
EJNMMI Research|June 25, 2020
Extravasation of [<sup>177</sup>Lu]Lu-DOTATOC: case report and discussionAnne Kirstine Arveschoug, Anne Charlotte Bekker, Peter Iversen, et al.
BMJ Open|December 29, 2020
What is the risk of prostate cancer mortality following negative systematic TRUS-guided biopsies? A systematic reviewSandra Miriam Kawa, Signe Benzon Larsen, John Thomas Helgstrand, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 22, 2006
Peripheral benzodiazepine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathyPeter Iversen, Dorthe Aagaard Hansen, Dirk Bender, et al.
BJU International|June 15, 2006
Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castrationChris J Tyrrell, Peter Iversen, Teuvo Tammela, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 28, 2024
Whole-body parametric mapping of tumour perfusion in metastatic prostate cancer using long axial field-of-view [<sup>15</sup>O]H<sub>2</sub>O PETMads Ryø Jochumsen, Nana L Christensen, Peter Iversen, et al.
Scandinavian Journal of Urology|August 2, 2017
The risk of biochemical recurrence for intermediate-risk prostate cancer after radical prostatectomySorel Kurbegovic, Kasper Drimer Berg, Frederik Birkebæk Thomsen, et al.
The Lancet. Oncology|January 18, 2017
Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based studyNina Klemann, M Andreas Røder, J Thomas Helgstrand, et al.
Scandinavian Journal of Urology|March 9, 2018
The use of transrectal ultrasound-guided biopsy following the introduction of prostate-specific antigen testing in Denmark: a population-based analysisNina Klemann, Martin Andreas Røder, John Thomas Helgstrand, et al.
The Prostate|December 24, 2005
Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinomaKlaus Brasso, Ib Jarle Christensen, Julia S Johansen, et al.
Pageof 16